Oligodendroglioma
📧 Sign up to get email alerts when something new happens for Oligodendroglioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma [EARLY_Phase 1]
Early-phase study evaluating the use of 18F-FDOPA PET imaging to plan surgery and radiation therapy for adults with newly diagnosed malignan…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
The PEAR-GLIO trial evaluating an AI R&D tool for adult gliomas and other primary brain tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Implantable Microdevice In Primary Brain Tumors [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating an implantable microdevice for primary brain tumors is currently recruiting across multiple gliom…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma [Phase 2]
Phase 2 trial comparing proton beam therapy with intensity-modulated radiation therapy for preserving brain function in IDH-mutant grade II/…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma
This completed clinical trial evaluated whole-brain tumor burden metrics along with inflammatory and molecular markers to predict postoperat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Study of Olutasidenib and Temozolomide in HGG [Phase 2]
Phase 2 study evaluating olutasidenib in combination with temozolomide for high-grade gliomas is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas [NA]
A clinical trial update for PRO-GLIO compares proton versus photon therapy in IDH-mutant diffuse gliomas and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of oral OKN-007 in adults with recurrent high-grade glioma. The trial includes patients …
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Update on the ProTRAIT proton therapy research infrastructure in neuro-oncology, with ongoing recruitment for several brain tumor conditions…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved [Phase 2]
Phase 2 trial evaluating safety and efficacy of palbociclib (CDK4/6 inhibitor) in patients with oligodendroglioma or recurrent oligoastrocyt…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma [Phase 1]
Phase 1 trial evaluating neo-adjuvant glioma lysate vaccines in WHO Grade II glioma has completed.
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Abemaciclib in Patients with Oligodendroglioma [Phase 2]
Abemaciclib is being studied in a Phase 2 trial for adults with oligodendroglioma. The study is currently listed as active but not recruitin…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: PARP Inhibition for Gliomas (PI-4G or π4g) [Phase 2]
Phase 2 trial of a PARP inhibitor for gliomas was terminated, with results posted in 2024, evaluating recurrent glioblastoma, recurrent astr…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes
This trial update reports late outcomes from radiotherapy in IDH-mutated gliomas, including astrocytoma grades II and III and oligodendrogli…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors [Phase 2]
Phase 2 pediatric brain tumor trial evaluating MRI-guided laser heat ablation to disrupt the peritumoral blood-brain barrier in order to imp…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma [Phase 2]
A Phase 2 clinical trial assessing the addition of plerixafor to standard temozolomide-based chemoradiotherapy for glioblastoma has complete…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) [Phase 1]
Phase 1 trial evaluating varlilumab in combination with the IMA950 vaccine and Poly-ICLC in adults with WHO grade II low-grade glioma; the s…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors [Phase 1]
The SJDAWN Phase 1 trial at St. Jude evaluated molecularly-driven doublet therapies for children and young adults with recurrent brain tumor…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Primary Chemotherapy by BCNU-TMZ Combination in Newly Diagnosed Anaplastic Oligodendrocytic Tumors: Phase II Trial With Translational Molecular Analysis [Phase 2]
Phase II trial evaluating primary chemotherapy with a BCNU-TMZ combination in newly diagnosed oligodendroglial tumors with translational mol…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas [Phase 1, Phase 2]
Clinical trial update on proton beam radiation therapy for various adult brain tumors, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma [Phase 2]
Phase 2 clinical trial update for a vaccine in newly diagnosed or recurrent low-grade glioma, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma [Phase 3]
Phase 3 trial evaluating post-radiation adjuvant temozolomide chemotherapy for residue low-grade glioma; recruiting status suggests ongoing …
-
CLINICAL_TRIALS withdrawal · 2020-03-24Clinical Trial Update: Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma [Phase 2, Phase 3]
Clinical trial evaluating Toca 511/Toca FC added to standard therapy for newly diagnosed glioblastoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: First in Patient Study for PF-06840003 in Malignant Gliomas [Phase 1]
Phase 1 trial update for PF-06840003 in malignant gliomas has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas [Phase 1]
Phase 1 trial evaluating alisertib in combination with fractionated stereotactic radiosurgery for adults with recurrent high-grade gliomas h…